JP2009516726A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009516726A5 JP2009516726A5 JP2008541808A JP2008541808A JP2009516726A5 JP 2009516726 A5 JP2009516726 A5 JP 2009516726A5 JP 2008541808 A JP2008541808 A JP 2008541808A JP 2008541808 A JP2008541808 A JP 2008541808A JP 2009516726 A5 JP2009516726 A5 JP 2009516726A5
- Authority
- JP
- Japan
- Prior art keywords
- filler
- parts
- pharmaceutical composition
- azd2171
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0523810.0A GB0523810D0 (en) | 2005-11-23 | 2005-11-23 | Pharmaceutical compositions |
| PCT/GB2006/004320 WO2007060402A1 (en) | 2005-11-23 | 2006-11-21 | Pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009516726A JP2009516726A (ja) | 2009-04-23 |
| JP2009516726A5 true JP2009516726A5 (enExample) | 2010-01-21 |
Family
ID=35601030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008541808A Pending JP2009516726A (ja) | 2005-11-23 | 2006-11-21 | 医薬組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20090028943A1 (enExample) |
| EP (2) | EP2283828A1 (enExample) |
| JP (1) | JP2009516726A (enExample) |
| KR (1) | KR20080070056A (enExample) |
| CN (2) | CN102327267A (enExample) |
| AR (1) | AR057928A1 (enExample) |
| AU (1) | AU2006318946A1 (enExample) |
| BR (1) | BRPI0618906A2 (enExample) |
| CA (1) | CA2628917A1 (enExample) |
| EC (1) | ECSP088555A (enExample) |
| GB (1) | GB0523810D0 (enExample) |
| NO (1) | NO20082097L (enExample) |
| RU (1) | RU2008125197A (enExample) |
| TW (1) | TW200735875A (enExample) |
| UY (1) | UY29952A1 (enExample) |
| WO (1) | WO2007060402A1 (enExample) |
| ZA (1) | ZA200804103B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0017548B8 (pt) * | 1999-02-10 | 2023-05-02 | Astrazeneca Ab | Composto |
| GB0330002D0 (en) | 2003-12-24 | 2004-01-28 | Astrazeneca Ab | Quinazoline derivatives |
| RU2519768C2 (ru) * | 2008-06-20 | 2014-06-20 | Мерк Патент Гмбх | Поддающаяся прямому прессованию и быстро распадающаяся матрица таблетки |
| WO2010005527A1 (en) | 2008-06-30 | 2010-01-14 | Angioblast Systems, Inc. | Treatment of eye diseases and excessive neovascularization using a combined therapy |
| TW201129386A (en) * | 2009-11-05 | 2011-09-01 | Fmc Corp | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients |
| WO2013059740A1 (en) | 2011-10-21 | 2013-04-25 | Foundation Medicine, Inc. | Novel alk and ntrk1 fusion molecules and uses thereof |
| EP4223770A3 (en) | 2012-11-05 | 2023-10-18 | Foundation Medicine, Inc. | Novel fusion molecules and uses thereof |
| HK1214830A1 (zh) | 2012-11-05 | 2016-08-05 | Foundation Medicine, Inc. | 新型ntrk1融合分子及其应用 |
| EP3939614A1 (en) | 2013-01-18 | 2022-01-19 | Foundation Medicine, Inc. | Methods of treating cholangiocarcinoma |
| KR20220164069A (ko) | 2013-06-06 | 2022-12-12 | 피브로겐, 인크. | Hif 하이드록실라제 억제자의 약학적 제형 |
| CA3012718A1 (en) | 2016-02-08 | 2017-08-17 | Vitrisa Therapeutics, Inc. | Compositions with improved intravitreal half-life and uses thereof |
| PE20221838A1 (es) * | 2020-04-24 | 2022-11-29 | Astrazeneca Ab | Formulaciones farmaceuticas |
| CN115400136B (zh) * | 2022-07-22 | 2023-10-03 | 江苏亚邦爱普森药业有限公司 | 一种克拉霉素固体制剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0017548B8 (pt) | 1999-02-10 | 2023-05-02 | Astrazeneca Ab | Composto |
| ES2292414T3 (es) * | 2000-07-27 | 2008-03-16 | Roquette Freres | Granulos a base de almidon y de lactosa. |
| SE0101329D0 (sv) * | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | Pharmaceutical formulation |
| CA2363528A1 (en) * | 2001-11-19 | 2003-05-19 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Immediate release tablet containing naproxen sodium |
| CN1625555A (zh) * | 2002-02-01 | 2005-06-08 | 阿斯特拉曾尼卡有限公司 | 喹唑啉化合物 |
| AU2003245313A1 (en) * | 2002-06-10 | 2003-12-22 | Elan Pharma International, Ltd | Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives (statins), novel combinations thereof as well as manufacturing of these pharmaceutical compositions |
| US20050043233A1 (en) * | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| GB0330002D0 (en) * | 2003-12-24 | 2004-01-28 | Astrazeneca Ab | Quinazoline derivatives |
-
2005
- 2005-11-23 GB GBGB0523810.0A patent/GB0523810D0/en not_active Ceased
-
2006
- 2006-11-17 TW TW095142644A patent/TW200735875A/zh unknown
- 2006-11-21 CN CN2011102142130A patent/CN102327267A/zh active Pending
- 2006-11-21 EP EP10182729A patent/EP2283828A1/en not_active Withdrawn
- 2006-11-21 KR KR1020087013620A patent/KR20080070056A/ko not_active Withdrawn
- 2006-11-21 BR BRPI0618906-7A patent/BRPI0618906A2/pt not_active IP Right Cessation
- 2006-11-21 WO PCT/GB2006/004320 patent/WO2007060402A1/en not_active Ceased
- 2006-11-21 US US12/094,702 patent/US20090028943A1/en not_active Abandoned
- 2006-11-21 EP EP06808603A patent/EP1954247A1/en not_active Withdrawn
- 2006-11-21 JP JP2008541808A patent/JP2009516726A/ja active Pending
- 2006-11-21 RU RU2008125197/15A patent/RU2008125197A/ru not_active Application Discontinuation
- 2006-11-21 AU AU2006318946A patent/AU2006318946A1/en not_active Abandoned
- 2006-11-21 CN CN200680043657XA patent/CN101312715B/zh not_active Expired - Fee Related
- 2006-11-21 CA CA002628917A patent/CA2628917A1/en not_active Abandoned
- 2006-11-22 UY UY29952A patent/UY29952A1/es unknown
- 2006-11-23 AR ARP060105180A patent/AR057928A1/es unknown
-
2008
- 2008-05-06 NO NO20082097A patent/NO20082097L/no not_active Application Discontinuation
- 2008-05-13 ZA ZA200804103A patent/ZA200804103B/xx unknown
- 2008-06-18 EC EC2008008555A patent/ECSP088555A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009516726A5 (enExample) | ||
| JP2009235073A5 (enExample) | ||
| HRP20151383T1 (hr) | Farmaceutski pripravci koji sadrže nilotinib ili njegovu sol | |
| CN105658208B (zh) | 含甘磷酸胆碱的薄膜包衣片剂及其制备方法 | |
| US20230341173A1 (en) | Wet granulation for manufacture of thermal insulation material | |
| HRP20120121T1 (hr) | Tabletiranje eritritola | |
| JP2016536285A (ja) | アムロジピン及びバルサルタンを含む安定な医薬組成物 | |
| JP2013514349A (ja) | 共加工された錠用賦形剤混合物、その調製及び使用 | |
| RU2008125197A (ru) | Фармацевтические композиции | |
| JP2012001473A5 (enExample) | ||
| Soh et al. | Torque rheological parameters to predict pellet quality in extrusion–spheronization | |
| TWI498130B (zh) | 以可直接壓縮高功能性粒狀微晶為主之賦形劑，其製造方法及用途 | |
| CN103142525B (zh) | 奥氮平胃溶型片剂及其制备方法 | |
| CN102846573B (zh) | 水飞蓟宾双层缓释片及其制备方法 | |
| WO2013017100A1 (zh) | 一种甲磺酸伊马替尼片剂 | |
| KR20100083047A (ko) | 생체이용률이 향상된 발사르탄을 포함하는 약제학적 조성물 | |
| IL200447A0 (en) | Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby | |
| JP2004243748A (ja) | 表層材と内層材を一体化した建材の製造方法 | |
| CN1226434C (zh) | 金属基复合材料增强相预构件的制备方法 | |
| JP2005508971A5 (enExample) | ||
| CN106220055B (zh) | 一种防止内墙返潮结露的防护板及其制备方法 | |
| JP2007001875A5 (enExample) | ||
| JP4774752B2 (ja) | 調湿用成形体とその製造方法 | |
| KR101544943B1 (ko) | 모델링 팩용 정제 조성물 및 이를 이용한 모델링 팩의 제조방법 | |
| CN1935264B (zh) | 一种用于缓控释片的含有hpmc的新型复合辅料 |